Skip to main content

International Psoriasis Council

Advancing Knowledge. Improving Care.

Anna

López Ferrer

,

MD, PhD

Consultant Dermatologist
Hospital de la Santa Creu i Sant Pau
Barcelona
,
Spain
Councilor Since: January 1, 2023
IPC Councilor
Dr. Anna López Ferrer is a Consultant Dermatologist in the Department of Dermatology at Hospital de la Santa Creu i Sant Pau in Barcelona, Spain. She holds a PhD in Biochemistry from the University of Barcelona and is an Associate Professor at the Universitat Autònoma de Barcelona.

Dr. López Ferrer is a member of the Board of Directors of the Spanish Academy of Dermatology and Venereology (AEDV) and currently coordinates the Spanish Psoriasis Group of the AEDV. Since 2012, she has led a collaborative clinic with the Department of Rheumatology focused on the integrated care of patients with psoriasis and psoriatic arthritis, with a particular interest in early diagnosis and treatment optimization.

She is actively engaged in national and international clinical research and has authored multiple peer-reviewed publications. Dr. López Ferrer is a member of the AEDV, the European Academy of Dermatology and Venereology (EADV), and the Educational Committee of the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA). She also serves as a Councilor of the International Psoriasis Council (IPC) and as the National Coordinator for the Global Psoriasis Atlas (GPA).
Last Updated:
07/10/2025

Areas of Interest

Psoriasis and the main comorbidities associated; psoriatic arthritis; biologics

Languages Spoken

Spanish

Involvement with Other Organization(s)

I am directly involved with the most important psoriasis patient association, Acción Psoriasis, with whom I have worked closely for the last decade. I have been consulted as an expert for preparing positioning reports of biological drugs after approval by the regulatory bodies in the region where I work.

What's New

Videos Now Available from the IPC Symposium at SID Chicago

Did you miss the IPC symposium at the 83rd Society for Investigative Dermatology (SID) Annual Meeting? Select session videos are now available. The Arc of Disease Control in Psoriasis: Early Interception – Deep Pathway Blockade – Treatment Failure covered early intervention strategies, treatment selection, immune pathway targeting, PsA prevention, clinical escape, and real-world cases that inform long-term psoriasis care.

WATCH NOW

Wednesday, June 17, 2026

Take Ten: Mio Nakamura – Psoriasis and Mental Health

Depression affects approximately 20% of patients with psoriasis, five times the rate seen in the general population. IPC Jr. Councilor Mio Nakamura, MD, MS, FAAD, walks through the bidirectional relationship between psoriasis and depression, the shared inflammatory pathways driving both conditions, and practical guidance on screening and incorporating multidisciplinary mental health support into psoriasis management.

WATCH NOW

Thursday, June 11, 2026